• OUR MISSION

    Improve the health of the people of Wisconsin by supporting and strengthening physicians' ability to practice high-quality patient care in a changing environment.

WMJ Vol. 118 No. 1: Original Research

Childhood Lead Poisoning in Wisconsin

 
Krista Christensen, PhD, MPH; Marjorie J. Coons, RN, MS; Reghan O. Walsh, BS; Jon Meiman, MD; Elizabeth Neary, MD, MS
 

 

Read the full article:
Download PDF       Appendix A   Appendix B

 

 

Abstract

Introduction: In 2016, 4,353 Wisconsin children under 6 years of age were identified with elevated blood lead levels (≥ 5 µg/dL). There is no safe level of lead in the human body; extensive research shows that children with blood lead levels < 5 µg/dL may still be at risk for adverse health effects including developmental delays.                                                                                                                                                                                 Discussion: Physicians should follow current guidelines and consider factors such as the child’s age, socioeconomic status, and housing situation when determining need for testing. In addition to Wisconsin’s screening recommendations, federal requirements exist for testing Medicaid enrolled children. Under state statute, all blood lead test results and specified demographic information must be reported to the Wisconsin Childhood Lead Poisoning Prevention Program. To eliminate elevated blood lead levels, primary prevention is key. Physicians play an important role by educating parents, prospective parents, and caregivers about lead poisoning risks and prevention measures. Physicians are also vital in secondary prevention—mitigating the adverse effects in children already exposed to lead. Secondary prevention requires first identifying children with elevated blood lead levels through appropriate testing. Use of the Wisconsin Blood Lead Registry can alert providers about children with elevated blood lead levels and reduce duplicate testing. Recent surveillance data show current screening is inadequate; in 2015, only 32% of Medicaid-enrolled children received appropriate testing. Physicians should provide clinical management for children with elevated blood levels and their families.

Conclusion: Physicians are a vital partner in preventing, identifying, and mitigating the effects of elevated blood lead levels for Wisconsin’s children.

Author Affiliations: Wisconsin Childhood Lead Poisoning Prevention Program, Wisconsin Department of Health Services, Division of Public Health, Bureau of Environmental and Occupational Health (Christensen, Coons, Walsh, Meiman); University of Wisconsin Hospital (Neary), Madison, Wis.

Corresponding Author: Jon Meiman, MD, Wisconsin Department of Health Services, 1 W Wilson St, Madison, WI 53703; email jonathan.meiman@dhs.wisconsin.gov.

Funding/Support: This research was funded by Cooperative Agreement Award Number 5NUE1EH001288-03-00, funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or the Department of Health and Human Services.

Financial Disclosures: None declared.